Previous studies of lopinavir/ritonavir (LPV/r) monotherapy have shown that over 70% of patients achieved HIV RNA levels <500 copies/mL over a follow-up period of 48 to 96 weeks, but the long-term durability is undetermined. Herein, the authors report 2 patients that started LPV/r monotherapy after virologic failure on an NNRTIbased regimen and have been successfully treated for greater than 7 years. Both patients demonstrated long-term control of viral replication over the course of treatment, although the first patient had 3 viral load blips and the second had 1 blip under 400 copies/mL. Both patients had increases in CD4+ lymphocyte counts. The first patient from 96 cells/microL to 378 cells/microL and the second patient from 71 cells/microL to 411 cells/microL. To the authors knowledge, these 2 cases represent the longest experience with LPV/r monotherapy and provide some measure of reassurance about the durability of LPV/r for control of HIV replication.
Tags
acne scar
Advanced Injector Trainings
cannula
Central Florida
Dr. Burt Lee
Dr. Gerald Pierone
Dr. Pierone
facial contouriing
facial rejuvenation
facialrejuvenationfl
Greer Hanson
HIV
innovative facial techniques
mintpdo
mintthreadliftflorida
Orlando
pdothreadlift
PDO Threads
PDO Thread Training
POD Cast